AME Company for Medical Supplies posted a net profit rise of 26% to SAR 33.5 million in 2023 from SAR 26.7 million in 2022.
| Item | 2022 | 2023 | Change |
|---|---|---|---|
| Revenues | 193.17 | 223.32 | 15.6 % |
| Gross Income | 90.28 | 98.75 | 9.4 % |
| Operating Income | 29.98 | 36.48 | 21.7 % |
| Net Income | 26.68 | 33.52 | 25.6 % |
| Average Shares | 7.00 | 7.00 | - |
| EPS (Riyals) | 3.81 | 4.79 | 25.6 % |
The company recorded a rise in the annual net revenue (net sales revenues) by SAR 30.15 million, mainly due to increased sales of medical supplies and medical equipment. This increase was backed by AME capturing a larger market share.
Shareholders’ equity, no minority interest, reached SAR 127.16 million as of Dec. 31, 2023, up from SAR 107.34 million a year earlier.
|
Historical Data |
|||
|
Period |
Revenue (SAR mln) |
Net Profit (SAR mln) |
EPS (SAR) |
|
H1 2020 |
44.66 |
4.18 |
0.60 |
|
H2 2020 |
76.94 |
16.89 |
2.41 |
|
H1 2021 |
69.78 |
7.50 |
1.07 |
|
H2 2021 |
81.61 |
13.72 |
1.96 |
|
H1 2022 |
108.35 |
15.38 |
2.20 |
|
H2 2022 |
84.82 |
11.30 |
1.61 |
|
H1 2023 |
120.34 |
22.20 |
3.17 |
|
H2 2023 |
102.98 |
11.32 |
1.62 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}